Recevez les dernières nouvelles sur l'action ARK Genomic Revolution ETF avec des mises à jour sur les tendances du marché, les données financières et les analyses de Benzinga. Restez informé des performances de ARKG

Dernières nouvelles pour

ARK Genomic Revolution Multi-Sector ETF

Healthcare

Other

The Fund is an actively managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80 percent of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the Funds investment theme of the genomics revolution (Genomics Revolution Companies). Under normal circumstances, substantially all of the Funds assets will be invested in equity securities, including common stocks, partnership interests, business trust shares and other equity investments or ownership interests in business enterprises. The Funds investments will include micro-, small-, medium- and large-capitalization companies. The Funds investments in foreign equity securities will be in both developed and emerging markets.

Twist Bioscience Corp.

Caredx

Crispr Therapeutics Ag

Recursion Pharmaceuticals, Inc.

Ionis Pharmaceuticals Inc

Intellia Therapeutics

Beam Therapeutics Inc

Schrodinger, Inc.

Adaptive Biotechnologies Corporation

10X Genomics Inc

Tempus Pe

Natera Inc

Guardant Health Inc.

Veracyte Inc (vcyt)

Personalis Inc Com

ARK Genomic Revolution ETF

Comments

ARK Genomic Revolution ETF Actualités boursières

Actualités

Dernières nouvelles pour

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL